Igc PharmaIGC
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 35 institutions reported holding Igc Pharma Inc. (IGC) in their 13F filings, up 7 from Q2 2025. 9 opened new positions and 2 sold out. The largest holders were Renaissance Technologies ($508K), Vanguard Group Inc. ($479K) and Geode Capital Management, LLC ($355K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Igc Pharma Inc.
- CUSIP
- 45408X308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $77K |
| Exits | 2 | $4K |
All 13F filers, Q2 2025 → Q3 2025: 2,451,555 shares bought and 49,366 shares sold, net +2,402,189 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Renaissance Technologies | 0.00% | Add +2115.3% | 1,218,965 | $508K |
| Vanguard Group Inc. | 0.00% | Add +78.1% | 1,149,268 | $479K |
| Geode Capital Management, LLC | 0.00% | Add +21.2% | 852,444 | $355K |
| BlackRock, Inc. | 0.00% | No change | 703,798 | $293K |
| Citadel Advisors | 0.00% | Add +131.7% | 627,840 | $262K |
| State Street Corp. | 0.00% | No change | 160,207 | $67K |
| Northern Trust Corp. | 0.00% | No change | 113,407 | $47K |
| Virtu Financial LLC | 0.00% | Add +91.0% | 89,546 | $37K |
| Dearborn Partners LLC | 0.00% | No change | 84,401 | $35K |
| Goldman Sachs Group Inc. | 0.00% | No change | 65,541 | $27K |
| HRT Financial LP | 0.00% | New | 60,258 | $25K |
| Fisher Asset Management | 0.00% | New | 43,400 | $18K |
| Truist Financial Corp. | 0.00% | No change | 36,667 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 34,948 | $15K |
| Two Sigma Securities, LLC | 0.00% | Add +196.0% | 35,028 | $15K |
| XTX Topco Ltd | 0.00% | Add +147.0% | 34,003 | $14K |
| Gsa Capital Partners LLP | 0.00% | New | 27,821 | $12K |
| Wolverine Trading, LLC | 0.00% | New | 18,479 | $8K |
| Morgan Stanley | 0.00% | No change | 17,707 | $7K |
| Susquehanna International Group, LLP | 0.00% | New | 13,962 | $6K |
| Thompson Davis & Co., Inc. | 0.00% | New | 10,000 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -17.7% | 9,793 | $4K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 13,961 | $4K |
| Group One Trading LLC | 0.00% | No change | 7,187 | $3K |
| Bank of America Corp. | 0.00% | Add +444.4% | 3,958 | $2K |
| UBS Group AG | 0.00% | Reduce -91.6% | 3,045 | $1K |
| Geneos Wealth Management Inc. | 0.00% | No change | 3,000 | $1K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 655 | $273 |
| Caitlin John, LLC | 0.00% | New | 200 | $83 |
| Hurley Capital, LLC | 0.00% | No change | 100 | $42 |
| Farther Finance Advisors, LLC | 0.00% | New | 100 | $42 |
| DHJJ Financial Advisors, Ltd. | 0.00% | No change | 80 | $34 |
| Evermay Wealth Management LLC | 0.00% | No change | 30 | $13 |
| FMR LLC | 0.00% | Reduce -95.4% | 5 | $2 |
| Simplex Trading, LLC | 0.00% | Reduce -65.4% | 212 | $0 |
"% of holder's portfolio" is IGC's weight in each manager's 13F, not the share of Igc Pharma Inc. the manager owns.